(株)カワチ薬品の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 小売業 | 2664/E03356 | CAWACHI LIMITED |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2018/08/17 | 日証協 | 256,926株 | +2.4% | 175,865株 | +124.24% | 312,505株 | +1.73% | 28,232株 | +59.5% |
2018/08/10 | 日証協 | 250,913株 | +0.9% | 78,427株 | -65.75% | 307,205株 | +4.49% | 17,700株 | -76.02% |
2018/08/03 | 日証協 | 248,682株 | +16.16% | 228,952株 | +236.07% | 294,005株 | +13.95% | 73,800株 | +254.81% |
2018/07/27 | 日証協 | 214,082株 | -4.85% | 68,127株 | +56.22% | 258,005株 | -1.83% | 20,800株 | +3.48% |
2018/07/20 | 日証協 | 224,992株 | 0% | 43,611株 | 0% | 262,805株 | 0% | 20,100株 | 0% |
2018/07/13 | 日証協 | 216,092株 | +2.71% | 61,500株 | -74.3% | 250,605株 | +9.72% | 33,500株 | -39.53% |
2018/07/06 | 日証協 | 210,382株 | +7.22% | 239,262株 | +847.95% | 228,405株 | +19.52% | 55,400株 | +106.6% |
2018/06/29 | 日証協 | 196,222株 | -3.33% | 25,240株 | -58.21% | 191,105株 | -6.91% | 26,815株 | -5.91% |
2018/06/22 | 日証協 | 202,982株 | +27.6% | 60,400株 | +187.02% | 205,290株 | +10.14% | 28,500株 | +8.78% |
2018/06/15 | 日証協 | 159,082株 | -3.73% | 21,044株 | +47.16% | 186,390株 | +2.61% | 26,200株 | +74.62% |
2018/06/08 | 日証協 | 165,238株 | -14.27% | 14,300株 | -75.48% | 181,646株 | -8.33% | 15,004株 | -36.96% |
2018/06/01 | 日証協 | 192,738株 | -0.99% | 58,328株 | +1032.8% | 198,142株 | -8.99% | 23,800株 | +1245.39% |
2018/05/25 | 日証協 | 194,658株 | -11.36% | 5,149株 | -75.24% | 217,711株 | -8.94% | 1,769株 | -80.02% |
2018/05/18 | 日証協 | 219,610株 | -26.19% | 20,792株 | -78.44% | 239,094株 | -29.27% | 8,852株 | -93.68% |
2018/05/11 | 日証協 | 297,528株 | +9.75% | 96,446株 | +64.86% | 338,042株 | +7.05% | 140,000株 | +213.9% |
2018/05/02 | 日証協 | 271,089株 | -4.88% | 58,500株 | -37.08% | 315,794株 | -3.4% | 44,600株 | -46.1% |
2018/04/27 | 日証協 | 284,989株 | +12.51% | 92,973株 | +33.93% | 326,894株 | +11.61% | 82,752株 | +383.62% |
2018/04/20 | 日証協 | 253,297株 | +4.33% | 69,421株 | -58.49% | 292,886株 | -2.94% | 17,111株 | -82.28% |
2018/04/13 | 日証協 | 242,775株 | +3.27% | 167,227株 | +308.27% | 301,757株 | -6.36% | 96,570株 | +329.09% |
※株式分割は考慮していませんのでご注意ください。
Page Top